About Sai Sridhar Pharma
Sai Sridhar Pharma is a Healthcare company based in Hyderabad (India) founded in 2022. It operates as a pharmaceutical distributor supplying medical products. It operates on a B2B model. The company has 21 employees. Its Indian entity Sai Sridhar Pharma Private Limited reported revenue of ₹349 Cr. Its focus areas include Pharmaceuticals, Distribution and Medical Products. Similar companies include AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales and 1 more; 3 of its 6 listed similar companies have raised funding.
Company details
Sai Sridhar Pharma, established in 2022, excels in providing healthcare solutions, producing pharmaceutical products, distribution, and medical products. Operates as a pharmaceutical distributor supplying medical products. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Hyderabad, India
- Employees 21
- SectorsHealthcare
- Website ssppltd.com
- Social LinkedIn YouTube
- Legal Name Sai Sridhar Pharma Private Limited
- Date of Incorporation 12 Oct, 2007
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹349 Cr
FY 2025 · -21% YoY
- Net Profit₹1.06 Cr
FY 2025 · 0% margin
- EBITDA₹2.08 Cr
FY 2025 · 1% margin
- Employee Count21
Associated legal entities of Sai Sridhar Pharma
Sai Sridhar Pharma operates through Sai Sridhar Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sai Sridhar Pharma Private Limited CIN U24232TG2007PTC055902 | Active | 12 Oct 2007 | Hyderabad, Telangana | ₹349 Cr | 21 | 4 | View details |
Apps and channels of Sai Sridhar Pharma
its YouTube channel MedPlus has 9.55K subscribers and 30 videos.
Videos from Sai Sridhar Pharma
The most watched videos on Sai Sridhar Pharma's YouTube channel, MedPlus (9.55K subscribers). Click a video to play it here.
More on MedPlus.
Board of directors of Sai Sridhar Pharma Private Limited (Sai Sridhar Pharma)
Sai Sridhar Pharma Private Limited is the primary company behind Sai Sridhar Pharma. The board of Sai Sridhar Pharma Private Limited currently have 4 directors; the longest-serving is Phani Srinivas Ramella, appointed in 2010. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Phani Srinivas Ramella DIN 03273162 | Director | 15 Mar 2010 | 16 yrs 7 mo | Sai Sridhar Pharma Private Limited |
| Paidiwar Srinivas DIN 00898824 | Director | 16 Oct 2017 | 9 yrs | Sai Sridhar Pharma Private Limited |
| Satya Murali Krishna Kammila DIN 01499290 | Director | 29 Sep 2021 | 5 yrs | Sai Sridhar Pharma Private Limited |
| Udaya Lakshmi Tadepalli DIN 06976534 | Additional Director | 23 May 2023 | 3 yrs 5 mo | Sai Sridhar Pharma Private Limited |
Financials of Sai Sridhar Pharma
Figures of Sai Sridhar Pharma Private Limited, the primary company behind Sai Sridhar Pharma, for FY 2025. Revenue was ₹349 Cr (-21% year on year). Net profit was ₹1.06 Cr (0% margin). EBITDA was ₹2.08 Cr (1% margin). Revenue has grown at a compounded annual rate of +2% over three years and +10% over five years.
- ₹349 CrRevenue · FY 2025 · -21% YoY
- ₹1.06 CrNet profit · 0% margin
- ₹2.08 CrEBITDA · 1% margin
- ₹2.4 LakhPaid-up capital
- 21Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sai Sridhar Pharma Private Limited are on its company page.
Detailed financial statements for Sai Sridhar Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Sai Sridhar Pharma
Sai Sridhar Pharma has 6 listed similar companies in our database, 3 of them funded. They include AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed similar companies of Sai Sridhar Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Sai Sridhar Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sai Sridhar Pharma
Sai Sridhar Pharma was founded in 2022.
Sai Sridhar Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Sai Sridhar Pharma has 21 employees.
The primary company behind Sai Sridhar Pharma, Sai Sridhar Pharma Private Limited, reported revenue of ₹349 Cr for FY 2025, down 21% year on year.
Sai Sridhar Pharma, established in 2022, excels in providing healthcare solutions, producing pharmaceutical products, distribution, and medical products. Operates as a pharmaceutical distributor supplying medical products. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Sai Sridhar Pharma's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Sai Sridhar Pharma operates through Sai Sridhar Pharma Private Limited.
The legal entities of Sai Sridhar Pharma currently have 4 directors, including Udaya Lakshmi Tadepalli, Phani Srinivas Ramella, Paidiwar Srinivas and others.